Time to rethink clinically important outcomes in platelet transfusion trials

被引：32

作者：

Heddle, Nancy M. ^{[1
]}

Arnold, Donald M.

Webert, Kathryn E.

机构：

[1] McMaster Univ, HSC 3H50, Dept Med, Hamilton, ON L8N 3Z5, Canada

来源：

TRANSFUSION | 2011年 / 51卷 / 02期

关键词：

SURROGATE END-POINTS; COMPOSITE OUTCOMES; RANDOMIZED-TRIALS; PREVENTION;

D O I：

10.1111/j.1537-2995.2010.02982.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：430 / 434

页数：5

共 23 条

[1] The use and abuse of surrogate endpoints in clinical research in transfusion medicine [J].

Arnold, Donald M. ;

Lim, Wendy .

TRANSFUSION, 2008, 48 (08) :1547-1549

[2] SURROGATE END-POINTS - A BASIS FOR A RATIONAL APPROACH [J].

BOISSEL, JP ;

COLLET, JP ;

MOLEUR, P ;

HAUGH, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (03) :235-244

[3] A COMPARISON OF FILTERED LEUKOCYTE-REDUCED AND CYTOMEGALOVIRUS (CMV) SERONEGATIVE BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CMV INFECTION AFTER MARROW TRANSPLANT [J].

BOWDEN, RA ;

SLICHTER, SJ ;

SAYERS, M ;

WEISDORF, D ;

CAYS, M ;

SCHOCH, G ;

BANAJI, M ;

HAAKE, R ;

WELK, K ;

FISHER, L ;

MCCULLOUGH, J ;

MILLER, W .

BLOOD, 1995, 86 (09) :3598-3603

[4] Users' guides to the medical literature XIX. Applying clinical trial results A. How to use an article measuring the effect of an intervention on surrogate end points [J].

Bucher, HC ;

Guyatt, GH ;

Cook, DJ ;

Holbrook, A ;

McAlister, FA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (08) :771-778

[5] A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology [J].

Cazenave, J. -P ;

Follea, G. ;

Bardiaux, L. ;

Boiron, J. -M. ;

Lafeuillade, B. ;

Debost, M. ;

Lioure, B. ;

Harousseau, J. -L. ;

Tabrizi, R. ;

Cahn, J. -Y ;

Michallet, M. ;

Ambruso, D. ;

Schots, R. ;

Tissot, J. -D. ;

Sensebe, L. ;

Kondo, T. ;

McCullough, J. ;

Rebulla, P. ;

Escolar, G. ;

Mintz, P. ;

Heddle, N. M. ;

Goodrich, R. P. ;

Bruhwyler, J. ;

Le, C. ;

Cook, R. J. ;

Stouch, B. .

TRANSFUSION, 2010, 50 (11) :2362-2375

[6] Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers [J].

Cook, RJ ;

Heddle, NM ;

Rebulla, P ;

Sigouin, CS ;

Webert, KE .

TRANSFUSION, 2004, 44 (08) :1135-1142

[7] Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review [J].

Cordoba, Gloria ;

Schwartz, Lisa ;

Woloshin, Steven ;

Bae, Harold ;

Gotzsche, Peter C. .

BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 :381

[8] Composite outcomes in randomized trials - Greater precision but with greater uncertainty? [J].

Freemantle, N ;

Calvert, M ;

Wood, J ;

Eastaugh, J ;

Griffin, C .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (19) :2554-2559

[9]

Gulliksson H, 2003, BLOOD, V101, P2426

[10] A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia [J].

Heddle, Nancy M. ;

Cook, Richard J. ;

Tinmouth, Alan ;

Kouroukis, C. Tom ;

Hervig, Tor ;

Klapper, Ellen ;

Brandwein, Joseph M. ;

Szczepiorkowski, Zbigniew M. ;

AuBuchon, James P. ;

Barty, Rebecca L. ;

Lee, Ker-Ai .

BLOOD, 2009, 113 (07) :1564-1573

← 1 2 3 →